Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/171056
Title: | SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2 |
Author: | Barroso Fernández, Emma Rodríguez-Rodríguez, Rosalia Zarei, Mohammad Pizarro Delgado, Javier Planavila Porta, Ana Palomer Tarridas, Francesc Xavier Villarroya i Gombau, Francesc Vázquez Carrera, Manuel |
Keywords: | Malalties del fetge Lípids Liver diseases Lipids |
Issue Date: | 10-Sep-2020 |
Publisher: | BioMed Central |
Abstract: | Background: Deficiency of mitochondrial sirtuin 3 (SIRT3), a NAD+ -dependent protein deacetylase that maintains redox status and lipid homeostasis, contributes to hepatic steatosis. In this study, we investigated additional mechanisms that might play a role in aggravating hepatic steatosis in Sirt3-deficient mice fed a high-fat diet (HFD). Methods: Studies were conducted in wild-type (WT) and Sirt3−/− mice fed a standard diet or a HFD and in SIRT3- knockdown human Huh-7 hepatoma cells. Results: Sirt3−/− mice fed a HFD presented exacerbated hepatic steatosis that was accompanied by decreased expression and DNA-binding activity of peroxisome proliferator-activated receptor (PPAR) α and of several of its target genes involved in fatty acid oxidation, compared to WT mice fed the HFD. Interestingly, Sirt3 deficiency in liver and its knockdown in Huh-7 cells resulted in upregulation of the nuclear levels of LIPIN1, a PPARα co-activator, and of the protein that controls its levels and localization, hypoxia-inducible factor 1α (HIF-1α). These changes were prevented by lipid exposure through a mechanism that might involve a decrease in succinate levels. Finally, Sirt3−/− mice fed the HFD showed increased levels of some proteins involved in lipid uptake, such as CD36 and the VLDL receptor. The upregulation in CD36 was confirmed in Huh-7 cells treated with a SIRT3 inhibitor or transfected with SIRT3 siRNA and incubated with palmitate, an effect that was prevented by the Nrf2 inhibitor ML385. Conclusion: These findings demonstrate new mechanisms by which Sirt3 deficiency contributes to hepatic steatosis |
Note: | Reproducció del document publicat a: https://doi.org/10.1186/s12964-020-00640-8 |
It is part of: | Cell Communication and Signaling, 2020, vol. 18, num. 147 |
URI: | http://hdl.handle.net/2445/171056 |
Related resource: | https://doi.org/10.1186/s12964-020-00640-8 |
ISSN: | 1478-811X |
Appears in Collections: | Articles publicats en revistes (Institut de Biomedicina (IBUB)) Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
703469.pdf | 2.68 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License